Development of second-generation probiotics as radiation mitigators
Active Definitive Contract Awarded Last action
- Contract number
- 75N93021C00008
- Awardee
-
Chromologic LLC UEI D9EVNTKKWLF3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,709,458
Award facts
- Opportunity
-
- 2020 NIAID Omnibus Broad Agency Announcement Pre-Solicitation · HHSNIHNIAIDBAA20201 · Posted Dec 11, 2019
- 2020 NIAID Omnibus Broad Agency Announcement Award Notice · Posted Mar 16, 2021
- 2020 NIAID Omnibus Broad Agency Announcement Solicitation · Posted Jan 3, 2020
- Contract value 100% obligated
- $2,709,458.08 Current and potential, with all options
- Completion date 93% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Monrovia, CA 91016, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $43,965 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Exercise an Option | $832,579 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $652,108 | |
| Exercise an Option | $834,191 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $346,615 |
Show all 18
About this award
The National Institute of Allergy and Infectious Diseases awarded a $2.7 million definitive contract to Chromologic LLC for development of second-generation probiotics as radiation mitigators on March 16, 2021. Chromologic is a minority-owned small business.
Place of performance is Monrovia, California. The originating pre-solicitation, posted in December 2019, sought proposals for advanced vaccine and therapeutic candidates, medical countermeasures, and diagnostics targeting infectious diseases including Ebola, Zika, influenza, and antibiotic-resistant bacteria, with a maximum performance period of five years. The contract is structured as cost-plus-fixed-fee pricing with an ultimate completion date of March 31, 2027.
Service Contract Inventory reporting shows the contract invoiced $33 thousand in FY2021 (0.1 FTEs, 253 hours), $403 thousand in FY2022 (0.9 FTEs, 1,791 hours), and $582 thousand in FY2023 (0.7 FTEs, 1,409 hours). Government-paid hourly rates rose year-over-year from $130.27/hour in FY2021 to $413.35/hour in FY2023. Chromologic self-performed all reported labor; no subcontractors were reported.
Quick answers
Who was awarded contract 75N93021C00008?
75N93021C00008 was awarded to Chromologic LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 16, 2021.
How much is contract 75N93021C00008 worth?
The government has obligated $2,709,458 on 75N93021C00008.
Was contract 75N93021C00008 competed?
The extent of competition for 75N93021C00008 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award